Biocon Biologics Receives EU GMP Certification for Its New Biologics Manufacturing Facility in Bengaluru Kumar Jeetendra | July 7, 2022 Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), has received a EU GMP certificate from the Health Products Regulatory Authority (HPRA), Ireland, for its new monoclonal antibodies (mAbs) drug substance manufacturing facility (B3) at Biocon Park, Bengaluru, following a GMP inspection in April 2022. The facility, spread across 340,000-square feet, …
